Get the Stockscreener App
1.15
0.88%
0.01
After Hours:
1.15
Vivani Medical Inc stock is traded at $1.15, with a volume of 55,436.
It is up +0.88% in the last 24 hours and up +11.65% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.14
Open:
$1.15
24h Volume:
55,436
Relative Volume:
0.64
Market Cap:
$74.65M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.3469
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
-8.73%
1M Performance:
+11.65%
6M Performance:
-13.53%
1Y Performance:
-28.57%
1-Day Range:
$1.13
$1.18
1-Week Range:
$1.11
$1.2775
52-Week Range:
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.15 | 74.65M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Stock (VANI) Latest News
Vivani Medical, Inc. (NASDAQ:VANI) Shares Purchased by Northern Trust Corp - Defense World
Vivani Stock Gains After Announcing Spin-Off Plans for Cortigent Unit - MSN
Companies To Watch: Vivani Medical - Life Science Leader
Vivani Medical spins off Cortigent as independent company By Investing.com - Investing.com South Africa
Vivani Medical Announces Spin-Off of Cortigent Subsidiary - TipRanks
Vivani Medical spins off Cortigent as independent company - Investing.com
Vivani (VANI) Plans to Spin Off Cortigent as an Independent Nasdaq Company | VANI Stock News - GuruFocus
Vivani Medical Announces Planned Spin-Off of Cortigent, Inc. as Independent Nasdaq Company in 2025 - Nasdaq
Vivani Medical Announces Filing of Form 10 Registration - GlobeNewswire
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders - Yahoo Finance
Brokers Issue Forecasts for Vivani Medical Q1 Earnings - MarketBeat
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars - MSN
Vivani Medical's (VANI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Brokers Offer Predictions for Vivani Medical Q1 Earnings - Defense World
Vivani Medical (NASDAQ:VANI) Given “Buy” Rating at HC Wainwright - Defense World
Vivani Medical Reports Q1 2025 Results and Strategic Updates - TipRanks
Vivani Medical (VANI) Receives Continued 'Buy' Rating from HC Wainwright | VANI Stock News - GuruFocus
Vivani Medical: Q1 Earnings Snapshot - CT Insider
Vivani Medical Secures $3 Million in Share Purchase - TipRanks
Vivani Medical Q1 Basic EPS USD -0.11 - marketscreener.com
Vivani Medical Provides Business Update Including $3M - GlobeNewswire
Vivani Medical (VANI) to Release Quarterly Earnings on Monday - MarketBeat
Vivani Medical (VANI) to Release Earnings on Monday - Defense World
Vivani Medical to Present at the American Association of - GlobeNewswire
Vivani Medical to Present at the American Association of Pharmaceutical Scientists' 'Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - The Manila Times
Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop - Yahoo Finance
Vivani Medical director Gregg Williams buys $1,124 in stock By Investing.com - Investing.com South Africa
Vivani Medical director Gregg Williams buys $1,124 in stock - Investing.com
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Vivani Medical Advances Drug Delivery Innovation with NanoPortal Technology - morgannewspaper.com
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - The Manila Times
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - AOL.com
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com Australia
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):